Applications of fluorescence in the characterization of the ligand-binding domain and activation of the cholecystokinin receptor

Pharmacology and Toxicology

Volumn 91, Issue 6, 2002, Pages 286-289

  Harikumar, Kaleeckal G ^a   Miller, Laurence J ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR; G PROTEIN COUPLED RECEPTOR; INDICATOR;

AGONIST; ANISOTROPY; CONFERENCE PAPER; FLUORESCENCE SPECTROSCOPY; HYDROPHILICITY; LIGAND BINDING; MOLECULAR DYNAMICS; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR OCCUPANCY; RECEPTOR UPREGULATION;

GTP-BINDING PROTEINS; LIGANDS; RECEPTORS, CHOLECYSTOKININ; SPECTROMETRY, FLUORESCENCE;

EID: 0036968634     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2002.910604.x     Document Type: Conference Paper

References (19)

1. Altenbach, C., J. Klein-Seetharaman, K. Cai, H. G. Khorana & W. L. Hubbell: Structure and function in rhodopsin: mapping light-dependent changes in distance between residue 316 in helix 8 and residues in the sequence 60-75, covering the cytoplasmic end of helices TM1 and TM2 and their connection loop CL1. Biochemistry 2001, 40, 15493-15500.
2. Beechem, J. M.: Global analysis of biochemical and biophysical data. Meth. Enzymol. 1992, 210, 37-54.
3. Bodanszky, M., J. C. Tolle, J.D. Gardner, M.D. Walker & V. Mutt: Cholecystokinin (pancreozymin). Synthesis and properties of the N alpha-acetyl-derivative of cholecystokinin 27-33. Int. J. Pept. Protein. Res. 1980, 16, 402-411.
4. Ding, X. Q., V. Dolu, E. M. Hadac, E. L. Holicky, D. I. Pinon, T. P. Lybrand & L. J. Miller: Refinement of the structure of the ligand-occupied cholecystokinin receptor using a photolabile amino-terminal probe. J. Biol. Chem. 2001, 276, 4236-4244.
5. Dong, M., X. Q. Ding, D. I. Pinon, E. M. Hadac, R. P. Oda, J. P. Landers & L. J. Miller: Structurally related peptide agonist, partial agonist, and antagonist occupy a similar binding pocket within the cholecystokinin receptor. Rapid analysis using fluorescent photoaffinity labeling probes and capillary electrophoresis. J. Biol. Chem. 1999, 274, 4778-4785. 4785.
6. Dunham, T. D. & D. L. Farrens: Conformational changes in rhodopsin. Movement of helix F detected by site-specific chemical labeling and fluorescence spectroscopy. J. Biol. Chem. 1999, 274, 1683-1690.
7. Gether, U., S. Lin & B. K. Kobilka: Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes. J. Biol. Chem. 1995, 270, 28268-28275.
8. Gether, U., S. Lin, P. Ghanouni, J. A. Ballesteros, H. Weinstein & B. K. Kobilka: Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor. EMBO J. 1997, 16, 6737-6747.
9. Gether, U. & B. K. Kobilka: G protein-coupled receptors. II. Mechanism of agonist activation. J. Biol. Chem. 1998, 273, 17979-17982.
10. 2-adrenergic receptor. J. Biol. Chem. 2001, 276, 24433-24436.
11. Hadac, E. M., D. I. Pinon, Z. Ji, E.L. Holicky, R. Henne, T.P. Lybrand & L. J. Miller: Direct identification of a second distinct site of contact between cholecystokinin and its receptor. J. Biol. Chem. 1998, 273, 12988-12993.
12. Harikumar, K. G., D. I. Pinon, W. S. Wessels, F. G. Prendergast & L. J. Miller: Environment and mobility of a series of fluorescent reporters at the amino-terminus of structurally-related peptide agonists and antagonists bound to the cholecystokinin receptor. J. Biol. Chem. 2002, 207, 18552-18560.
13. Hubbell, W. L., D. S. Cafiso & C. Altenbach: Identifying conformational changes with site-directed spin labeling. Nature Struct. Biol. 2000, 7, 735-739.
14. Ji, Z., E. M. Hadac, R. M. Henne, S. A. Patel, T. P. Lybrand, & L. J. Miller: Direct identification of a distinct site of interaction between the carboxyl-terminal residue of cholecystokinin and the type A cholecystokinin receptor using photoaffinity labeling. J. Biol. Chem. 1997, 272, 24393-24401.
15. Ji, T. H., M. Grossmann & I. Ji: G-protein coupled receptors I. Diversity of receptor - ligand interactions. J. Biol. Chem. 1998, 273, 17299-17302.
16. Lakowicz, J. R.: Principles of fluorescence spectroscopy. Kluwer/Plenum Press, New York, 1999, pp. 238-289.
17. 19F nuclear Overhauser effects in structural studies of the cytoplasmic domain of mammalian rhodopsin. Proc. Natl. Acad. Sci. USA 2001, 98, 4888-4892.
18. Lu, Z.-L., J. W. Saldanha & E. C. Hulme: Seven-transmembrane receptors: crystals clarify. Trends Pharmacol. Sci. 2002, 23, 140-146.
19. Palczewski, K., T. Kumasaka, T. Hori, C. A. Behnke, H. Motoshima, B. A. Fox, I. Le. Trong, D. C. Teller, T. Okada, R. E. Stenkamp, M. Yamamoto & M. Miyano: Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000, 289, 739-745.